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Background
Knowledge and avoidance of allergies can lead to better
allergy symptom control. The AIRS study assessed
approaches to diagnosis of nasal and eye allergies or
allergic rhinoconjunctivitis in the US.
Methods
A national sample of 34,030 households using a dual
frame approach of random digit dialing and cell phone
sample were targeted. Patients aged =5 years with a health
care professional diagnosis of hay fever, allergic rhinitis,
rhino-conjunctivitis, nasal or eye allergies and symptoms
or medication for condition in past 12 months were
surveyed. Data on specific diagnosis and allergy testing
were collected.
Results
Based on screening land-line sample of 20,835 households,
18% of individuals were diagnosed with one of conditions
of interest. Of the 2765 surveyed patients, 86% were diag-
nosed with nasal allergies, 59%, hay fever, 54% eye aller-
gies, 30%, allergic rhinitis and 13%, rhinoconjunctivitis.
Four percent of respondents reported they were given an
allergy test by doctor or health professional in past four
months, 3% in past year, 7%, 1-2 years ago, and 37%, 3 or
more years ago. Of those, 71% reported that they had a
skin prick test, 13% had blood test and 12% had both
blood and skin prick test. 47% report they never received
an allergy test.
Conclusions
The AIRS survey demonstrated that 18% of individuals > 5
years were diagnosed with an above allergic condition.
Although these respondents had been diagnosed by a
health care professional with “allergies”, almost half never
had any allergy testing to determine the triggers of their
condition.
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